Effectiveness, Adverse Events, and Immune Response Following Double Vaccination with BNT162b2 in Staff at the National Comprehensive Cancer Center (NCCC)

Vaccination remains the leading strategy against COVID-19 worldwide. BNT162b2 is among the first licensed vaccines with high effectiveness. However, the role of antibody and cell immunity response monitoring after vaccination remains unclear. We conducted a 6-month prospective study involving the em...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Patrik Palacka, Monika Pol’anová, Alena Svobodová, Jan Žigmond, Katarína Zanchetta, Vlasta Gombárová, Martina Vulganová, Ján Slopovský, Jana Obertová, Ľuboš Drgoňa, Michal Mego, Juraj Pechan
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2022-04-01
Colecção:Vaccines
Assuntos:
BNT162b2
effectiveness
adverse events
IgG antibodies
cell-mediated immunity
Acesso em linha:https://www.mdpi.com/2076-393X/10/4/558
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados